PAA 4.88% 19.5¢ pharmaust limited

Ann: Resignation of Dr Michael Thurn & appointment of John Clark, page-121

  1. 500 Posts.
    lightbulb Created with Sketch. 178
    Does it matter that much that MT is leaving in 4 months with ODD decision and phase 2/3 study beginning before he leaves. Won't be a lot to do for 6 months other than report interim results and wait for midway point of study.

    All participants are now taking 10mg/kg/day as cohort 2 did in below phase 1 trial. CSF NfL level reduced markedly more in cohort 2 compared to cohort 1 (granted only 3 participants measured). ALS function rating score slower decline at higher dose.

    RvR too good to ignore for this stock.
    https://hotcopper.com.au/data/attachments/6121/6121064-7682c6f2782541ff2fbec09a49fb62e9.jpg
    https://hotcopper.com.au/data/attachments/6121/6121067-80d9fa0865f3150e7fdec6f8ca09e160.jpg
    Last edited by adzconan: 23/04/24
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
19.5¢
Change
-0.010(4.88%)
Mkt cap ! $94.79M
Open High Low Value Volume
20.5¢ 20.5¢ 19.5¢ $188.9K 946.5K

Buyers (Bids)

No. Vol. Price($)
12 800531 19.0¢
 

Sellers (Offers)

Price($) Vol. No.
19.5¢ 49199 1
View Market Depth
Last trade - 16.10pm 29/07/2024 (20 minute delay) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.